HOME >> MEDICINE >> NEWS
Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

(PHILADELPHIA) -- The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, the researchers say.

The team of scientists including first author Jose Moreno, M.D., clinical associate professor of urology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and the Kimmel Cancer Center at Jefferson looked at circulating tumor cells (CTCs) in 240 men with metastatic prostate cancer that failed hormone-depletion therapy. They compared levels prior to chemotherapy and after two to five weeks of treatment. They found that those men with more than five tumor cells per blood sample had a worse prognosis than those who had fewer cells. One half of the patients with more than five CTCs lived at least 10 months, whereas half of the men with fewer tumor cells lived substantially longer 21 months.

Dr. Moreno presents the trials findings June 4, 2007 at the annual meeting of the American Society of Clinical Oncology in Chicago.

The results of the 65-site trial also showed that those patients who underwent chemotherapy and whose CTC number went down fared better and had a more favorable prognosis. That is, the level of response to chemotherapy was reflected in the CTC level, notes Dr. Moreno. The numbers held up even after up to 20 weeks of treatment. If chemotherapy doesnt reduce the CTC level, its information that enables the physician to change the drug regimen or perhaps stop treatment, he says.

Dr. Moreno notes that the prostate specific antigen has been a powerful biomarker for cancer presence and a useful way to gauge treatment effectiveness for years, though it has some flaws. He thinks that th
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
4-Jun-2007


Page: 1 2

Related medicine news :

1. Trial stops after stroke and mortality significantly reduced by blood
2. Trials underway for essential new TB vaccine
3. ENDEAVOR III Trial reports key findings on new-generation stent
4. NIH names Clinical Trial Units for the Microbicide Trials Network
5. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
6. The Public Library of Science launches the new open access journal PLoS Clinical Trials
7. Trial shows vaccine against cervical cancer provides long-term protection
8. Trial shows malaria vaccine could protect young children from disease for 18 months
9. Trial demonstrates new drugs effectiveness against psoriasis
10. Trial at Jefferson shows new drug may help cancer patients who need stem cell transplants
11. Second implant of US Pilot Trial achieved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... 2020 , ... In an effort to give back to the community in ... each hotel room booked with a special new rate code to benefit children and ... effective immediately. Donations will be applied to any room type, any time, now ...
(Date:8/29/2020)... MONTREAL (PRWEB) , ... August 29, 2020 , ... When ... - perhaps with greater ease than most people would. Rather than become melancholic, however, ... yet deep advice on achieving one’s dreams. Randy Pausch took a negative situation and ...
(Date:8/28/2020)... Calif. (PRWEB) , ... August 28, 2020 , ... ... cover a one-year subscription to a customized Lighthouse Health & Wellness mobile app ... support of this project. Motorola Solutions Foundation awards grants each year to organizations, ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ziegler, a specialty ... its investment in Synchronous Health, a tech-enabled behavioral health and well-being solutions provider. ... human empathy with artificial intelligence (AI) to increase access and quality of behavioral ...
(Date:8/27/2020)... VEGAS (PRWEB) , ... August 27, 2020 , ... ... their doors! Sikara Medspa is a leading aesthetic and wellness retreat. The practice ... area and surrounding areas of Las Vegas. , Designed to be a ...
Breaking Medicine News(10 mins):
(Date:8/28/2020)... ... 2020 , ... Dr. Mark Surrey has been in practice for over ... clinical professor in the Department of OBGYN at UCLA’s David Geffen School of Medicine. ... Reproductive Society and is a Clinical Director of Fellowship Training for UCLA & Cedars ...
(Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... ... coordination software, today announced the successful completion of their 2020 System and Organizational ... as their HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect their ...
(Date:8/27/2020)... ... ... season is right round the corner and the risk of getting caught by influenza is ... begins to harbor its effects on us. Already with the sudden outbreak of COVID 19, ... lives. Hence it has become even more relevant to keep oneself immune from any of ...
Breaking Medicine Technology:
Cached News: